期刊文献+

Id3-EGFP融合基因表达载体的构建及其在人肺癌细胞A549中的表达 被引量:5

Construction of Id3-EGFP eukaryotic expression vector and its expression in A549 cells
原文传递
导出
摘要 目的构建人分化抑制因子3(Id3)与增强型绿色荧光蛋白(EGFP)的融合基因表达载体pEGFP/Id3,使Id3-EGFP融合蛋白在人肺癌细胞A549中得到表达。方法扩增并克隆人Id3cDNA,构建Id3和EGFP的融合基因表达载体pEGFP/Id3。用脂质体转染技术将pEGFP/Id3导入A549细胞,使Id3-EGFP融合蛋白在A549细胞得到表达。结果经转化细菌、抽提质粒、酶切鉴定和DNA序列分析证实,Id3基因已正确插入pEGFP-N1中EGFP基因的上游,获得融合基因表达载体pEGFP/Id3。利用脂质体转染技术将pEGFP和pEGFP/Id3转入A549细胞,24h后,在激光共聚焦荧光显微镜下可观察到表达EGFP的细胞发出绿色荧光,流式细胞术分析表明,转染48h时EGFP阳性表达细胞率最高,分别可达65·40%和60·50%。pEGFP/Id3转染的A549细胞S期细胞和G2期细胞比例均明显高于pEGFP转染细胞组和未转染细胞组,表明Id3基因的导入可诱导细胞从G1期向G2期发展,从而促进细胞增殖。结论真核表达载体pEGFP/Id3的成功构建及其在A549细胞中的表达,为研究Id3的细胞定位表达及Id3在细胞生长调控中的作用奠定了实验基础。 Objective To construct eukaryotic expression vector for human differentiation inhibitor3 (Id3) fused with enhanced green fluorescent protein (EGFP) and express the fusion protein Id3-EGFP in A549 cells. Methods The human Id3 cDNA was amplified and inserted into the pEGFP-N1 vector to construct the recombinant eukaryotic expression vector pEGFP/Id3. The fusion protein Id3-EGFP was expressed in A549 cells by transfection of Id3/pEGFP into the cells. Results The pEGFP/Id3 recombinant expression vector was constructed and confirmed by DNA sequencing, enzymatic digestion and PCR identification. Both pEGFP-N1 and pEGFP/Id3 were transfected into human A549 cells by LipofectamineTM 2000. Flow cytometry analysis revealed that 48 h after transfection, the proportions of EGFP + cells of pEGFP-N1 and pEGFP/Id3 transfected cells were about 65.40% and 60. 50% respectively. The cell proportions in S phase and G2 phase increased in A549 transfected with Id3/pEGFP in comparison with A549 cells transfected with pEGFG-N1 or no transfected. These findings suggested that transfection of Id3 gene into A549 induced cell proliferation by increasing the number of cells from G1 phase to G2 phases. Conclusion The construction of pEGFP/Id3 eukaryotic expression vector and expression of Id3-EGFP fusion protein in A549 cells provide a foundation for the further study of the relationship between Id3 and growth and proliferation of tumor cells.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2006年第12期1111-1115,共5页 Chinese Journal of Laboratory Medicine
基金 江苏省"六大人才高峰"基金资助课题(苏卫科教[2005]6号) 江苏省"135工程"医学重点人才基金资助课题(RC2002024)
关键词 分化抑制因子 肺肿瘤 重组融合蛋白 differentiation inhibitor Lung neoplasms recombinant fusion protein
  • 相关文献

参考文献2

二级参考文献29

  • 1Singh J, Murata K, Itahana Y, et al. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.Oneogene, 2002, 21 (12): 1812 ~ 1822
  • 2Ling M T, Wang X, Ouyang X S, et al. Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth. Oncogene, 2002, 21 (55): 8498 -8505
  • 3Ling M T, Wang X, Ouyang X S, et al. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Oncogene, 2003, 22 (29): 4498 - 4508
  • 4Benezra R, Davis R L, Lockshon D, et al. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell, 1990, 61 (1):49-59
  • 5Norton J D. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci, 2000, 113 (Pt.22): 3897 - 3905
  • 6Ruzinova M B, Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol, 2003, 13 (8): 410 -418
  • 7Yokota Y, Mori S. Role of Id family proteins in growth control. J Cell Physiol, 2002, 190 (1): 21 -28
  • 8Ohtani N, Zebedee Z, Huot T J, et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence.Nature, 2001, 409 (6823): 1067 - 1070
  • 9Yates P R, Atherton G T, Deed R W, et al. Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors. EMBO J, 1999, 18 (4): 968 -976
  • 10Kee B L, Rivera R R, Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF β. Nat Immunol,2001,2 (3):242-247

共引文献30

同被引文献33

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部